ENTITY

FibroBiologics (FBLG US)

8
Analysis
Health Care • United States
FibroBiologics, Inc. operates as an early stage, cell therapy company. The Company develops food and drug administration trials related to fibroblast treatments for degenerative disc disease, multiple sclerosis, cancer, wound healing, and other diseases. FibroBiologics serves clients in the United States.
more
Exchange Announcement • 25 Nov 2025 21:31
Exchange Announcement • 25 Nov 2025 21:30
Exchange Announcement • 20 Nov 2025 05:53
Exchange Announcement • 01 Nov 2025 04:05
Exchange Announcement • 09 Aug 2025 04:05
x